Urologix, Inc. reported earnings results for the third quarter and nine months ended March 31, 2014. The company has reported that net loss for the third quarter ended March 31, 2014 was $1.66 million, or $0.08 loss per share, compared to a net loss of $1 million, or $0.05 loss per share, for the same quarter ended March 31, 2013. Sales for the third quarter ended March 31, 2014 were $3.36 million, compared to $4.08 million for the same quarter ended March 31, 2013.

Net loss for the nine months ended March 31, 2014 was $4.08 million, or $0.19 loss per share, compared to a net loss of $3.04 million, or $0.15 loss per share, for the same period ended March 31, 2013. Sales for the nine months ended March 31, 2014 were $10.94 million, compared to $12.40 million for the same period ended March 31, 2013.